Next report date
Report period
Q2 2024
EPS estimate
0.33EUR
Revenue estimate
1.66 BEUR
1.27EUR
2.09 BEUR
7.14 BEUR
610.28 M
About CHUGAI PHARMACEUT'L
Sector
CEO
Osamu Okuda
Headquarters
Tokyo
Website
Employees (FY)
7.6 K
Founded
1925
ISIN
JP3519400000
FIGI
BBG000C3NZ97
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CUP is 28.60 EUR — it has decreased by 5.67% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CHUGAI PHARMACEUT'L stocks are traded under the ticker CUP.
CHUGAI PHARMACEUT'L is going to release the next earnings report on Jul 25, 2024. Keep track of upcoming events with our Earnings Calendar.
CUP stock is 6.46% volatile and has beta coefficient of 0.98. Check out the list of the most volatile stocks — is CHUGAI PHARMACEUT'L there?
CUP earnings for the last quarter are 0.36 EUR per share, whereas the estimation was 0.33 EUR resulting in a 9.18% surprise. The estimated earnings for the next quarter are 0.29 EUR per share. See more details about CHUGAI PHARMACEUT'L earnings.
CHUGAI PHARMACEUT'L revenue for the last quarter amounts to 1.76 B EUR despite the estimated figure of 1.83 B EUR. In the next quarter revenue is expected to reach 1.49 B EUR.
Yes, you can track CHUGAI PHARMACEUT'L financials in yearly and quarterly reports right on TradingView.
CUP stock has fallen by 5.30% compared to the previous week, the month change is a 19.66% fall, over the last year CHUGAI PHARMACEUT'L has showed a 25.44% increase.
CUP net income for the last quarter is 585.62 M EUR, while the quarter before that showed 491.08 M EUR of net income which accounts for 19.25% change. Track more CHUGAI PHARMACEUT'L financial stats to get the full picture.
Today CHUGAI PHARMACEUT'L has the market capitalization of 51.01 B, it has decreased by 0.05% over the last week.
CHUGAI PHARMACEUT'L dividend yield was 1.50% in 2023, and payout ratio reached 40.44%. The year before the numbers were 2.32% and 34.26% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, CUP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CHUGAI PHARMACEUT'L stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 7.60 K employees. See our rating of the largest employees — is CHUGAI PHARMACEUT'L on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CHUGAI PHARMACEUT'L technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CHUGAI PHARMACEUT'L stock shows the neutral signal. See more of CHUGAI PHARMACEUT'L technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CHUGAI PHARMACEUT'L future price: according to them, CUP price has a max estimate of 44.60 EUR and a min estimate of 27.08 EUR. Read a more detailed CHUGAI PHARMACEUT'L forecast: see what analysts think of CHUGAI PHARMACEUT'L and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CHUGAI PHARMACEUT'L EBITDA is 2.75 B EUR, and current EBITDA margin is 40.26%. See more stats in CHUGAI PHARMACEUT'L financial statements.